What are analysts'target prices for Trulieve cannabis'stock?
11 brokerages have issued twelve-month target prices for Trulieve Cannabis' stock. Their forecasts range from $31.00 to $132.00. On average, they anticipate Trulieve Cannabis' stock price to reach $69.97 in the next twelve months. This suggests a possible upside of 95.5% from the stock's current price.
Is Trulieve (TRX) stock a great value?
Based on 9 unanimous Buys, consensus on the Street is that Trulieve is a Strong Buy. The average analyst price target of $69.74 implies 78% upside potential. Owing to heightened investor interest in Cannabis stocks, Trulieve shares have seen an approximate 301% gain over the past year.
What will Trulieve cannabis stock price rise in the next year?
On average, they expect Trulieve Cannabis' share price to reach $76.66 in the next year. This suggests a possible upside of 201.7% from the stock's current price.
Will Trulieve cannabis (tcnnf) outperform or underperform the S&P 500?
Vote “Outperform” if you believe TCNNF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TCNNF will underperform the S&P 500 over the long term. You may vote once every thirty days. Trulieve Cannabis does not currently pay a dividend. Trulieve Cannabis does not have a long track record of dividend growth.
See more
Is Trulieve on the US stock market?
TCNNF Stock Price | Trulieve Cannabis Corp. Stock Quote (U.S.: OTC) | MarketWatch.
Can you buy Trulieve stocks?
Shares of Trulieve cannot be purchased directly from the company, however, stock can be purchased through brokerage firms.
How much does it cost to buy stock in Trulieve?
What is Trulieve Cannabis' stock price today? One share of TCNNF stock can currently be purchased for approximately $13.56.
Does Trulieve pay dividends?
No. Trulieve does not currently pay a dividend or offer a dividend reinvestment plan (DRIP).
Should I invest in Trulieve stock?
On many measures Trulieve is at the top in performance and potential. Successful investing means investing in companies that will be successful. The chances of doing this are greatly improved by picking companies that have a proven record of success. Trulieve gets my Strong Buy recommendation.
Why is Trulieve stock falling?
Trulieve is still 'digesting' last year's $2.1 billion acquisition: CEO. Kim Rivers, the CEO of Florida-based Trulieve, told Yahoo Finance that the company's $32 million net loss this past quarter and 42.8% year-to-date drop in its stock can be attributed in part to its acquisition of Harvest Health and Recreation.
Who owns Trulieve in Florida?
Kim RiversKim Rivers is the CEO of Trulieve, Florida's first and leading medical cannabis company and one of the most profitable American cannabis companies.
What company owns Trulieve?
Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company is a multi-state operator in the United States operating in states, with market positions in Arizona, Florida, and Pennsylvania....TRULIEVE CANNABIS CO.Delayed - 07/20 03:59:47 pm16.7CAD+2.02%
Is Curlf stock a buy?
According to the issued ratings of 9 analysts in the last year, the consensus rating for Curaleaf stock is Moderate Buy based on the current 2 hold ratings and 7 buy ratings for CURLF.
How many states is Trulieve in?
11 statesTrulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania.
Where is Trulieve based out of?
Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.
How long has Trulieve been in business?
Trulieve was one of the state's first medical marijuana operators, launching after Florida lawmakers in 2014 approved non-euphoric cannabis for patients with severe epilepsy. The company blossomed after Florida voters in 2016 passed a constitutional amendment that broadly legalized medical marijuana.
Should I buy or sell Trulieve Cannabis stock right now?
9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trulieve Cannabis in the last twelve months. There are currently...
What is Trulieve Cannabis' stock price forecast for 2022?
9 Wall Street analysts have issued 1-year price objectives for Trulieve Cannabis' shares. Their forecasts range from $47.00 to $135.00. On average,...
How has Trulieve Cannabis' stock price performed in 2022?
Trulieve Cannabis' stock was trading at $26.01 at the start of the year. Since then, TCNNF shares have decreased by 46.1% and is now trading at $14...
Are investors shorting Trulieve Cannabis?
Trulieve Cannabis saw a increase in short interest in May. As of May 31st, there was short interest totaling 453,400 shares, an increase of 22.8% f...
When is Trulieve Cannabis' next earnings date?
Trulieve Cannabis is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forecast for...
How were Trulieve Cannabis' earnings last quarter?
Trulieve Cannabis Corp. (OTCMKTS:TCNNF) issued its quarterly earnings results on Monday, November, 15th. The company reported $0.14 EPS for the qua...
What guidance has Trulieve Cannabis issued on next quarter's earnings?
Trulieve Cannabis issued an update on its FY 2022 earnings guidance on Thursday, June, 9th. The company provided earnings per share (EPS) guidance...
Who are Trulieve Cannabis' key executives?
Trulieve Cannabis' management team includes the following people: Ms. Kimberly Rivers , Founder, Chairman & CEO (Age 43, Pay $4.3M) Mr. Alex D'A...
Who are some of Trulieve Cannabis' key competitors?
Some companies that are related to Trulieve Cannabis include Abacus Health Products (ABAHF) , Acreage (ACRGF) , Alliance Growers (ACGWF) , Alth...
What is Trulieve Cannabis?
Is Trulieve a US company?
Trulieve Cannabis Corp. ("Trulieve" or the "Company") (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the Unit ed States, today announced the closing of the acquisition of Solevo Wellness West Virginia LLC ("Solevo") and its three West Virginia dispensary permits.
TRU Precious Metals Contracts Simcoe Geoscience for IP Survey at Golden Rose Project
Trulieve Cannabis Corp. ("Trulieve" or the "Company") (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States, today announced its results for the quarter ended March 31, 2021. The Company became a U.S. reporting company effective February 4, 2021 and the consolidated financial statements are reported in accordance with U.S. Generally Accepted Accounting Principles (GAAP). All currency is expressed in U.S. dollars.
TRU Precious Metals Appoints Stephen Lautens as President
Toronto, Ontario-- (Newsfile Corp. - February 9, 2022) - TRU Precious Metals Corp.
TRU Precious Metals Announces Completion of Drill Program at Golden Rose Project in Central Newfoundland and Reports Gold in Initial Assay Results
Toronto, Ontario-- (Newsfile Corp. - January 31, 2022) - TRU Precious Metals Corp. (TSXV: TRU) (OTCQB: TRUIF) (FSE: 706) ("TRU" or the "Company") is pleased to announce that, subject to regulatory approval, Stephen Lautens has been appointed President of the Company, effective February 1, 2022.
